Literature DB >> 11565214

Torsade de pointes induced by ajmaline.

W Haverkamp1, G Mönnig, P Kirchhof, L Eckardt, M Borggrefe, G Breithardt.   

Abstract

Ajmaline, a reserpine derivative, is an effective class I antiarrhythmic agent. Herein we report two cases of ajmaline-induced abnormal QT prolongation accompanied by polymorphic ventricular tachycardia of the torsade de pointes type. Since ajmaline is increasingly used for the acute termination of wide complex tachycardia and as a diagnostic tool after syncope and in patients with idiopathic ventricular tachyarrhythmias, our observations suggest that caution should be exercised with regard to the effects of the drug on the QT interval and its potency to induce proarrhythmia of the torsade de pointes type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565214     DOI: 10.1007/s003920170128

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

1.  Syncope of a drug addict - a special case.

Authors:  Bidisha Chatterjee; Ulrich Bürgi
Journal:  Clin Res Cardiol       Date:  2006-08-01       Impact factor: 5.460

2.  Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.

Authors:  Claudia Kiesecker; Edgar Zitron; Sonja Lück; Ramona Bloehs; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Volker A W Kreye; Hugo A Katus; Wolfgang Schoels; Christoph A Karle; Johann Kiehn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-30       Impact factor: 3.000

3.  Sex-Specific Classification of Drug-Induced Torsade de Pointes Susceptibility Using Cardiac Simulations and Machine Learning.

Authors:  Alex Fogli Iseppe; Haibo Ni; Sicheng Zhu; Xianwei Zhang; Raffaele Coppini; Pei-Chi Yang; Uma Srivatsa; Colleen E Clancy; Andrew G Edwards; Stefano Morotti; Eleonora Grandi
Journal:  Clin Pharmacol Ther       Date:  2021-04-19       Impact factor: 6.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.